Moderna, BioNTech on the rise amid concerns over new variant, China outbreak

Many vaccine makers are surging in Monday trading amid concerns over a new COVID-19 variant, deltacron, and as China experiences its worst outbreak since early 2020.
Moderna (MRNA +17.6%), BioNTech (BNTX +15.9%), and Novavax (NVAX +9.3%) are among the top gainers.
On Friday, the World Health Organization said that some cases of deltacron had been recorded in Denmark, France, and the Netherlands.
On Saturday, China's National Health Commission reported 3,122 cases, the highest number since the Wuhan outbreak in January 2020, CNN reported.
Other vaccine names: Pfizer (PFE +4.4%), Johnson & Johnson (JNJ +2.2%), and AstraZeneca (AZN +1.4%).
A report earlier Monday said that uptake of Novavax's (NVAX +10.1%) vaccine in Europe has been slow.